Medline Reports Q3 Sales of $7.9B
Medline reported strong Q3 sales and guidance but a drop in net income. The company authorized a $1B share repurchase program.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
START FREE — 10,000 calls/day, no key needed